PDE4A and fatty liver disease: Growing evidence indicates that PDE4 dysregulation is of pathophysiological importance in metabolic disorders through its involvement in multiple processes, including inflammation, disordered glucose and lipid metabolism, and hepatic steatosis [12–14].